
Rabetrade D 30mg/20mg Tablet SR
Marketer
Zovaitalia Healthcare Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabetrade D 30mg/20mg Tablet SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Rabetrade D 30mg/20mg SR tablets, a dual-action formulation. This medication alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Rabetrade D should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration is determined by your response and overall condition. Premature discontinuation may lead to symptom recurrence and potential worsening of GERD. Always disclose all medications to your healthcare provider, as interactions are possible. Common, generally transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until the medicine's impact is known. Alcohol consumption should be avoided due to potential increased sleepiness. Dietary adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, may enhance treatment outcomes. Prior to commencing treatment, inform your doctor about any pre-existing liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding.
Uses of Rabetrade D 30mg/20mg Tablet SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabetrade D 30mg/20mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Rabetrade D 30mg/20mg Extended-Release Tablet on an empty stomach.
Common Side effects of Rabetrade D 30mg/20mg Tablet SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabetrade D 30mg/20mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Rabetrade D 30mg/20mg Sustained-Release Tablet on an empty stomach.
How Rabetrade D 30mg/20mg Tablet SR works:
Rabetrade D 30mg/20mg sustained-release tablets contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabetrade D 30mg/20mg Tablet SR concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Rabetrade D 30mg/20mg Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Rabetrade D (30mg/20mg) is likely unsuitable for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving should be avoided if taking Rabetrade D 30mg/20mg SR tablets, as drowsiness, dizziness, and visual disturbances are potential side effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Rabetrade D 30mg/20mg sustained-release tablets. Dosage modification of Rabetrade D 30mg/20mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Rabetrade D 30mg/20mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Rabetrade D 30mg/20mg SR tablets are contraindicated in patients with moderate to severe hepatic dysfunction.
What if you forget to take Rabetrade D 30mg/20mg Tablet SR :
Should you forget to take your Rabetrade D 30mg/20mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabetrade D 30mg/20mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
